Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
76.96 EUR | -1.71% |
|
-.--% | -.--% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 10.72B | - | ||
+4.65% | 80.78B | C+ | ||
-12.58% | 33.93B | B- | ||
-10.91% | 30.8B | A- | ||
-12.54% | 15.25B | B | ||
+3.49% | 14.3B | B+ | ||
-13.91% | 7.26B | B | ||
+4.30% | 3.27B | B- | ||
-15.85% | 2.71B | C+ | ||
-30.27% | 2.4B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AKZA Stock
- AKZO Stock
- Ratings AkzoNobel